Skip to main content
PMC home page
Gut logoLink to Gut
. 1993 Apr;34(4):509–513. doi: 10.1136/gut.34.4.509

Increased absorption of polyethylene glycol 600 deposited in the colon in active ulcerative colitis.

S Almer 1, L Franzén 1, G Olaison 1, K Smedh 1, M Ström 1
PMCID: PMC1374312  PMID: 8491399

Abstract

A defect in the barrier function of the intestinal mucosa has been proposed as important in both the pathogenesis and systemic manifestations of inflammatory bowel disease. After colonoscopy, polymers of polyethylene glycol (PEG) with molecular weights of 414-810 (mean 600), were instilled in the descending colon of patients with ulcerative colitis (n = 17) and in controls without intestinal inflammation (n = 8). The patients with active ulcerative colitis (n = 6) had a significantly increased uptake of PEGs in the molecular weight range 458-810, measured as urinary excretion over the first 6 hours after instillation. The median values for their excretion were 2.85-3.80% of PEGs instilled compared with 0.32-0.94% for patients in remission (n = 11) (p < 0.05-0.01) and 0.17-0.60% for the controls (p < 0.05-0.01). The differences in absorption of PEG 414 did not reach the present level of statistical significance. There was a positive correlation between PEG absorption and the endoscopic and histological grading of inflammatory activity in the sigmoid colon (p < 0.01-0.001). These findings support a correlation between the presence of active inflammation and PEG absorption. There was little evidence to support the presence of a primary defect in the colonic barrier in patients with ulcerative colitis.

Full text

PDF
512

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BARON J. H., CONNELL A. M., LENNARD-JONES J. E. VARIATION BETWEEN OBSERVERS IN DESCRIBING MUCOSAL APPEARANCES IN PROCTOCOLITIS. Br Med J. 1964 Jan 11;1(5375):89–92. doi: 10.1136/bmj.1.5375.89. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bjarnason I., O'Morain C., Levi A. J., Peters T. J. Absorption of 51chromium-labeled ethylenediaminetetraacetate in inflammatory bowel disease. Gastroenterology. 1983 Aug;85(2):318–322. [PubMed] [Google Scholar]
  3. Black D. A. Intestinal permeability in the elderly. Dig Dis Sci. 1988 Mar;33(3):382–382. doi: 10.1007/BF01535768. [DOI] [PubMed] [Google Scholar]
  4. Casellas F., Aguadé S., Soriano B., Accarino A., Molero J., Guarner L. Intestinal permeability to 99mTc-diethylenetriaminopentaacetic acid in inflammatory bowel disease. Am J Gastroenterol. 1986 Sep;81(9):767–770. [PubMed] [Google Scholar]
  5. Chadwick V. S., Mellor D. M., Myers D. B., Selden A. C., Keshavarzian A., Broom M. F., Hobson C. H. Production of peptides inducing chemotaxis and lysosomal enzyme release in human neutrophils by intestinal bacteria in vitro and in vivo. Scand J Gastroenterol. 1988 Jan;23(1):121–128. doi: 10.3109/00365528809093861. [DOI] [PubMed] [Google Scholar]
  6. Chadwick V. S., Phillips S. F., Hofmann A. F. Measurements of intestinal permeability using low molecular weight polyethylene glycols (PEG 400). II. Application to normal and abnormal permeability states in man and animals. Gastroenterology. 1977 Aug;73(2):247–251. [PubMed] [Google Scholar]
  7. Cobden I., Rothwell J., Axon A. T. Intestinal permeability and screening tests for coeliac disease. Gut. 1980 Jun;21(6):512–518. doi: 10.1136/gut.21.6.512. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Delpre G., Avidor I., Steinherz R., Kadish U., Ben-Bassat M. Ultrastructural abnormalities in endoscopically and histologically normal and involved colon in ulcerative colitis. Am J Gastroenterol. 1989 Sep;84(9):1038–1046. [PubMed] [Google Scholar]
  9. Fantozzi R., Brunelleschi S., Rubino A., Tarli S., Masini E., Mannaioni P. F. FMLP-activated neutrophils evoke histamine release from mast cells. Agents Actions. 1986 Apr;18(1-2):155–158. doi: 10.1007/BF01988009. [DOI] [PubMed] [Google Scholar]
  10. Gebbers J. O., Otto H. F. Alterations of the intestinal mucosal block in ulcerative colitis and Crohn's disease--immunological and ultrastructural findings, and considerations of the pathogenesis. Klin Padiatr. 1985 Jul-Aug;197(4):341–348. doi: 10.1055/s-2008-1034000. [DOI] [PubMed] [Google Scholar]
  11. Gibson P. R., van de Pol E., Barratt P. J., Doe W. F. Ulcerative colitis--a disease characterised by the abnormal colonic epithelial cell? Gut. 1988 Apr;29(4):516–521. doi: 10.1136/gut.29.4.516. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Ginsberg A. L., Beck L. S., McIntosh T. M., Nochomovitz L. E. Treatment of left-sided ulcerative colitis with 4-aminosalicylic acid enemas. A double-blind, placebo-controlled trial. Ann Intern Med. 1988 Feb;108(2):195–199. doi: 10.7326/0003-4819-108-2-195. [DOI] [PubMed] [Google Scholar]
  13. Granger D. N., Zimmerman B. J., Sekizuka E., Grisham M. B. Intestinal microvascular exchange in the rat during luminal perfusion with formyl-methionyl-leucyl-phenylalanine. Gastroenterology. 1988 Mar;94(3):673–681. doi: 10.1016/0016-5085(88)90238-7. [DOI] [PubMed] [Google Scholar]
  14. Grisham M. B., Gaginella T. S., von Ritter C., Tamai H., Be R. M., Granger D. N. Effects of neutrophil-derived oxidants on intestinal permeability, electrolyte transport, and epithelial cell viability. Inflammation. 1990 Oct;14(5):531–542. doi: 10.1007/BF00914274. [DOI] [PubMed] [Google Scholar]
  15. Hodgson H. J., Potter B. J., Jewell D. P. Immune complexes in ulcerative colitis and Crohn's disease. Clin Exp Immunol. 1977 Aug;29(2):187–196. [PMC free article] [PubMed] [Google Scholar]
  16. Hollander D. Crohn's disease--a permeability disorder of the tight junction? Gut. 1988 Dec;29(12):1621–1624. doi: 10.1136/gut.29.12.1621. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Hollander D., Koyama S., Dadufalza V., Tran D. Q., Krugliak P., Ma T., Ling K. Y. Polyethylene glycol 900 permeability of rat intestinal and colonic segments in vivo and brush border membrane vesicles in vitro. J Lab Clin Med. 1989 Apr;113(4):505–515. [PubMed] [Google Scholar]
  18. Hollander D., Vadheim C. M., Brettholz E., Petersen G. M., Delahunty T., Rotter J. I. Increased intestinal permeability in patients with Crohn's disease and their relatives. A possible etiologic factor. Ann Intern Med. 1986 Dec;105(6):883–885. doi: 10.7326/0003-4819-105-6-883. [DOI] [PubMed] [Google Scholar]
  19. ISLEY J. K., SANDERS A. P., SHARPE K. W., REEVES R. J., BAYLIN G. J. The use of radioactive isotopes in the study of colonic absorption. Am J Roentgenol Radium Ther Nucl Med. 1959 Jan;81(1):89–92. [PubMed] [Google Scholar]
  20. Jenkins A. P., Trew D. R., Crump B. J., Nukajam W. S., Foley J. A., Menzies I. S., Creamer B. Do non-steroidal anti-inflammatory drugs increase colonic permeability? Gut. 1991 Jan;32(1):66–69. doi: 10.1136/gut.32.1.66. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Jenkins R. T., Goodacre R. L., Rooney P. J., Bienenstock J., Sivakumaran T., Walker W. H. Studies of intestinal permeability in inflammatory diseases using polyethylene glycol 400. Clin Biochem. 1986 Oct;19(5):298–302. doi: 10.1016/s0009-9120(86)80045-5. [DOI] [PubMed] [Google Scholar]
  22. Jenkins R. T., Jones D. B., Goodacre R. L., Collins S. M., Coates G., Hunt R. H., Bienenstock J. Reversibility of increased intestinal permeability to 51Cr-EDTA in patients with gastrointestinal inflammatory diseases. Am J Gastroenterol. 1987 Nov;82(11):1159–1164. [PubMed] [Google Scholar]
  23. Katz D., Hollander D., Said H. M., Dadufalza V. Aging-associated increase in intestinal permeability to polyethylene glycol 900. Dig Dis Sci. 1987 Mar;32(3):285–288. doi: 10.1007/BF01297055. [DOI] [PubMed] [Google Scholar]
  24. Kingham J. G., Loehry C. A. Permeability of the small intestine after intra-arterial injection of histamine-type mediators and irradiation. Gut. 1976 Jul;17(7):517–526. doi: 10.1136/gut.17.7.517. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Krugliak P., Hollander D., Le K., Ma T., Dadufalza V. D., Katz K. D. Regulation of polyethylene glycol 400 intestinal permeability by endogenous and exogenous prostanoids. Influence of non-steroidal anti-inflammatory drugs. Gut. 1990 Apr;31(4):417–421. doi: 10.1136/gut.31.4.417. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. LEVITAN R., BIKERMAN V., BURROWS B. A., INGELFINGER F. J. RECTOSIGMOIDAL ABSORPTION OF PHENOLSULFONPHTHALEIN (PSP), SULFISOXAZOLE DIETHANOLAMINE (GANTRISIN), AND RADIOIODINE (I-131) IN NORMAL SUBJECTS AND PATIENTS WITH IDIOPATHIC ULCERATIVE COLITIS. J Lab Clin Med. 1963 Oct;62:639–645. [PubMed] [Google Scholar]
  27. Lauritsen K., Laursen L. S., Bukhave K., Rask-Madsen J. In vivo profiles of eicosanoids in ulcerative colitis, Crohn's colitis, and Clostridium difficile colitis. Gastroenterology. 1988 Jul;95(1):11–17. doi: 10.1016/0016-5085(88)90284-3. [DOI] [PubMed] [Google Scholar]
  28. LeDuc L. E., Nast C. C. Chemotactic peptide-induced acute colitis in rabbits. Gastroenterology. 1990 Apr;98(4):929–935. doi: 10.1016/0016-5085(90)90017-u. [DOI] [PubMed] [Google Scholar]
  29. Magnusson K. E., Dahlgren C., Sjölander A. Effect of N-formylated methionyl-phenylalanine (FMP) and methionyl-leucyl-phenylalanine (FMLP) on gut permeability. A model of local inflammatory process. Inflammation. 1985 Dec;9(4):365–373. doi: 10.1007/BF00916336. [DOI] [PubMed] [Google Scholar]
  30. Marasco W. A., Phan S. H., Krutzsch H., Showell H. J., Feltner D. E., Nairn R., Becker E. L., Ward P. A. Purification and identification of formyl-methionyl-leucyl-phenylalanine as the major peptide neutrophil chemotactic factor produced by Escherichia coli. J Biol Chem. 1984 May 10;259(9):5430–5439. [PubMed] [Google Scholar]
  31. Marin M. L., Greenstein A. J., Geller S. A., Gordon R. E., Aufses A. H., Jr A freeze fracture study of Crohn's disease of the terminal ileum: changes in epithelial tight junction organization. Am J Gastroenterol. 1983 Sep;78(9):537–547. [PubMed] [Google Scholar]
  32. McCormick D. A., Horton L. W., Mee A. S. Mucin depletion in inflammatory bowel disease. J Clin Pathol. 1990 Feb;43(2):143–146. doi: 10.1136/jcp.43.2.143. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Mee A. S., McLaughlin J. E., Hodgson H. J., Jewell D. P. Chronic immune colitis in rabbits. Gut. 1979 Jan;20(1):1–5. doi: 10.1136/gut.20.1.1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Miller M. J., Zhang X. J., Barkemeyer B., Sadowska-Krowicka H., Eloby-Childress S., Gu X., Clark D. A. Potential role of histamine monochloramine in a rabbit model of ileitis. Scand J Gastroenterol. 1991 Aug;26(8):852–858. doi: 10.3109/00365529109037022. [DOI] [PubMed] [Google Scholar]
  35. Nash S., Stafford J., Madara J. L. Effects of polymorphonuclear leukocyte transmigration on the barrier function of cultured intestinal epithelial monolayers. J Clin Invest. 1987 Oct;80(4):1104–1113. doi: 10.1172/JCI113167. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Nast C. C., LeDuc L. E. Chemotactic peptides. Mechanisms, functions, and possible role in inflammatory bowel disease. Dig Dis Sci. 1988 Mar;33(3 Suppl):50S–57S. doi: 10.1007/BF01538131. [DOI] [PubMed] [Google Scholar]
  37. O'Morain C. A., Abelow A. C., Chervu L. R., Fleischner G. M., Das K. M. Chromium 51-ethylenediaminetetraacetate test: a useful test in the assessment of inflammatory bowel disease. J Lab Clin Med. 1986 Nov;108(5):430–435. [PubMed] [Google Scholar]
  38. Olaison G., Leandersson P., Sjödahl R., Tagesson C. Increase in permeability and phospholipase A2 activity of colonic mucosa in Crohn's colitis. Digestion. 1989;43(4):228–233. doi: 10.1159/000199881. [DOI] [PubMed] [Google Scholar]
  39. Olaison G., Sjödahl R., Tagesson C. Abnormal intestinal permeability in Crohn's disease. A possible pathogenic factor. Scand J Gastroenterol. 1990 Apr;25(4):321–328. doi: 10.3109/00365529009095493. [DOI] [PubMed] [Google Scholar]
  40. Olaison G., Sjödahl R., Tagesson C. Decreased gastrointestinal absorption of peroral polyethyleneglycols (PEG 1000) in Crohn's disease. A sign of jejunal abnormality. Acta Chir Scand. 1987;153(5-6):373–377. [PubMed] [Google Scholar]
  41. Painter R. G., Sklar L. A., Jesaitis A. J., Schmitt M., Cochrane C. G. Activation of neutrophils by N-formyl chemotactic peptides. Fed Proc. 1984 Sep;43(12):2737–2742. [PubMed] [Google Scholar]
  42. Peled Y., Watz C., Gilat T. Measurement of intestinal permeability using 51Cr-EDTA. Am J Gastroenterol. 1985 Oct;80(10):770–773. [PubMed] [Google Scholar]
  43. Pironi L., Miglioli M., Ruggeri E., Levorato M., Dallasta M. A., Corbelli C., Nibali M. G., Barbara L. Relationship between intestinal permeability to [51Cr]EDTA and inflammatory activity in asymptomatic patients with Crohn's disease. Dig Dis Sci. 1990 May;35(5):582–588. doi: 10.1007/BF01540405. [DOI] [PubMed] [Google Scholar]
  44. Podolsky D. K., Isselbacher K. J. Glycoprotein composition of colonic mucosa. Specific alterations in ulcerative colitis. Gastroenterology. 1984 Nov;87(5):991–998. [PubMed] [Google Scholar]
  45. Ramage J. K., Hunt R. H., Perdue M. H. Changes in intestinal permeability and epithelial differentiation during inflammation in the rat. Gut. 1988 Jan;29(1):57–61. doi: 10.1136/gut.29.1.57. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Rampton D. S., Sladen G. E. Relationship between rectal mucosal prostaglandin production and water and electrolyte transport in ulcerative colitis. Digestion. 1984;30(1):13–22. doi: 10.1159/000199086. [DOI] [PubMed] [Google Scholar]
  47. Resnick R. H., Royal H., Marshall W., Barron R., Werth T. Intestinal permeability in gastrointestinal disorders. Use of oral [99mTc]DTPA. Dig Dis Sci. 1990 Feb;35(2):205–211. doi: 10.1007/BF01536764. [DOI] [PubMed] [Google Scholar]
  48. Saweirs W. M., Andrews D. J., Low-Beer T. S. The double sugar test of intestinal permeability in the elderly. Age Ageing. 1985 Sep;14(5):312–315. doi: 10.1093/ageing/14.5.312. [DOI] [PubMed] [Google Scholar]
  49. Shorter R. G., Huizenga K. A., Spencer R. J. A working hypothesis for the etiology and pathogenesis of nonspecific inflammatory bowel disease. Am J Dig Dis. 1972 Nov;17(11):1024–1032. doi: 10.1007/BF02239143. [DOI] [PubMed] [Google Scholar]
  50. Tagesson C., Andersson P. A., Andersson T., Bolin T., Källberg M., Sjödahl R. Passage of molecules through the wall of the gastrointestinal tract. Measurement of intestinal permeability to polyethylene glycols in the 634-1338 dalton range (PEG 1000). Scand J Gastroenterol. 1983 May;18(4):481–486. doi: 10.3109/00365528309181626. [DOI] [PubMed] [Google Scholar]
  51. Walker W. A., Isselbacher K. J. Uptake and transport of macromolecules by the intestine. Possible role in clinical disorders. Gastroenterology. 1974 Sep;67(3):531–550. [PubMed] [Google Scholar]
  52. Ward M. The pathogenesis of Crohn's disease. Lancet. 1977 Oct 29;2(8044):903–905. doi: 10.1016/s0140-6736(77)90835-2. [DOI] [PubMed] [Google Scholar]
  53. Watts J. M., Thompson H., Goligher J. C. Sigmoidoscopy and cytology in the detection of microscopic disease of the rectal mucosa in ulcerative colitis. Gut. 1966 Jun;7(3):288–294. doi: 10.1136/gut.7.3.288. [DOI] [PMC free article] [PubMed] [Google Scholar]
  54. Williams L. T., Snyderman R., Pike M. C., Lefkowitz R. J. Specific receptor sites for chemotactic peptides on human polymorphonuclear leukocytes. Proc Natl Acad Sci U S A. 1977 Mar;74(3):1204–1208. doi: 10.1073/pnas.74.3.1204. [DOI] [PMC free article] [PubMed] [Google Scholar]
  55. Zellweger U., Freiburghaus A. U., Münch R., Meyenberger C., Bühler H., Ammann R. Messung der Darmpermeabilität bei Morbus Crohn, Colitis ulcerosa, Sprue und idiopathischer Hyperamylasämie mit Polyethylenglykol-400. Schweiz Med Wochenschr. 1990 Apr 28;120(17):617–620. [PubMed] [Google Scholar]
  56. von Ritter C., Sekizuka E., Grisham M. B., Granger D. N. The chemotactic peptide N-formyl methionyl-leucyl-phenylalanine increases mucosal permeability in the distal ileum of the rat. Gastroenterology. 1988 Sep;95(3):651–656. doi: 10.1016/s0016-5085(88)80011-8. [DOI] [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES